Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04720755 · ClinicalTrials.gov registry record · NA
Low Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) for Erectile Dysfunction
A NA study, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT04720755: Completed NA study, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
NCT04720755 is a NA study that has completed, run by Hunter Holmes Mcguire Veteran Affairs Medical Center. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04720755, a NA study, has completed, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Low-intensity extracorporeal shock wave therapy (Li-ESWT) has shown promise as a novel treatment for erectile dysfunction (ED), though the the mechanism of action and optimal protocol for administration has not been well-established. The aim of this study is to assess for subjective and objective improvements in erectile function following treatment with Li-ESWT.
Primary Outcome
To evaluate the efficacy of the Storz Duolith SD-1 T-top \>\>ultra\<\< Li-ESWT device
Interventions
- DEVICE Low-Intensity Extracorporeal Shock Wave Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2023-09-21 |
| Phase | NA |
What the finished NCT04720755 record still lists
NCT04720755 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Low-Intensity Extracorporeal Shock Wave Therapy is the first listed.
NCT04720755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04720755 about?
NCT04720755 is a clinical study titled "Low Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) for Erectile Dysfunction". Low-intensity extracorporeal shock wave therapy (Li-ESWT) has shown promise as a novel treatment for erectile dysfunction (ED), though the the mechanism of action and optimal protocol for administration has not been well-established. The aim of this study is to assess for subjective and objective im...
What is the current status of trial NCT04720755?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2021-03-01. Estimated completion is 2023-09-21.
What interventions are being tested in trial NCT04720755?
The interventions under investigation include: Low-Intensity Extracorporeal Shock Wave Therapy (DEVICE).
Who is sponsoring clinical trial NCT04720755?
This trial is sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04720755's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI